Edward G Robins Selected Research

Neoplasms (Cancer)

2/2022	Imaging Kv1.3 Expressing Memory T Cells as a Marker of Immunotherapy Response.
1/2022	Granzyme B PET Imaging in Response to In Situ Vaccine Therapy Combined with αPD1 in a Murine Colon Cancer Model.
10/2021	Granzyme B PET Imaging of Combined Chemotherapy and Immune Checkpoint Inhibitor Therapy in Colon Cancer.
10/2020	Granzyme B PET Imaging of Immune Checkpoint Inhibitor Combinations in Colon Cancer Phenotypes.
1/2020	Examining Immunotherapy Response Using Multiple Radiotracers.
5/2015	Pharmacokinetics of Gd(DO3A-Lys) and MR imaging studies in an orthotopic U87MG glioma tumor model.
3/2014	Negative contrast Cerenkov luminescence imaging of blood vessels in a tumor mouse model using [68Ga]gallium chloride.
1/2014	An intravascular MRI contrast agent based on Gd(DO3A-Lys) for tumor angiography.
12/2012	Gadolinium chelate with DO3A conjugated 2-(diphenylphosphoryl)-ethyldiphenylphosphonium cation as potential tumor-selective MRI contrast agent.
1/2011	Radiosynthesis and pre-clinical evaluation of [(18)F]fluoro-[1,2-(2)H(4)]choline.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Edward G Robins Research Topics

Disease

10	Neoplasms (Cancer) 02/2022 - 01/2011
5	Colonic Neoplasms (Colon Cancer) 02/2022 - 01/2020
3	Cerebrovascular Disorders (Cerebrovascular Occlusion) 10/2021 - 01/2020
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 10/2021
1	Alzheimer Disease (Alzheimer's Disease) 10/2021
1	Atrophy 10/2021
1	Dementia (Dementias) 10/2021
1	Adenoma (Adenomas) 08/2021
1	Hyperaldosteronism (Conn Syndrome) 08/2021
1	Hyperplasia 08/2021
1	Disease Progression 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2021
1	Malaria 01/2021
1	Parasitemia 01/2021
1	Autoimmune Diseases (Autoimmune Disease) 08/2020
1	Parkinson Disease (Parkinson's Disease) 01/2020
1	Vascular Diseases (Vascular Disease) 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2019
1	Ischemic Stroke 01/2019
1	Infarction (Infarctions) 01/2019
1	Glioma (Gliomas) 05/2015
1	Breast Neoplasms (Breast Cancer) 01/2011

Drug/Important Bio-Agent (IBA)

4	Immune Checkpoint InhibitorsIBA 02/2022 - 10/2020
3	Granzymes (Granzyme)IBA 01/2022 - 10/2020
3	Biomarkers (Surrogate Marker)IBA 10/2021 - 01/2020
3	Amyloid (Amyloid Fibrils)IBA 10/2021 - 01/2020
2	Peptides (Polypeptides)IBA 10/2021 - 10/2020
2	GadoliniumIBA 01/2014 - 12/2012
2	Contrast MediaIBA 01/2014 - 12/2012
1	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 02/2022
1	Fluorouracil (Carac)FDA LinkGeneric 10/2021
1	Amyloid beta-PeptidesIBA 10/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2021
1	Fluorine-18IBA 10/2021
1	metomidateIBA 08/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Antimalarials (Antimalarial Agents)IBA 01/2021
1	FluorineIBA 10/2020
1	AntigensIBA 08/2020
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2020
1	RadiopharmaceuticalsIBA 01/2020
1	Small Interfering RNA (siRNA)IBA 01/2019
1	triphenyltetrazoliumIBA 01/2019
1	Hemoglobins (Hemoglobin)IBA 01/2019
1	Epidermal Growth Factor (EGF)IBA 01/2019
1	Evans Blue (Blue, Evans)FDA Link 01/2019
1	Tyrosine Kinase InhibitorsIBA 01/2019
1	gallium chlorideIBA 03/2014
1	LigandsIBA 12/2012
1	CationsIBA 12/2012
1	Radioisotopes (Radionuclides)IBA 12/2012
1	Molecular Probes (Molecular Probe)IBA 12/2012
1	gadoteridol (Prohance)FDA Link 12/2012
1	triphenylphosphoniumIBA 12/2012
1	Deoxyglucose (2 Deoxy D glucose)IBA 01/2011
1	fluorocholineIBA 01/2011
1	compound 18IBA 01/2011
1	Choline (Choline Chloride)IBA 01/2011

Therapy/Procedure

5	Therapeutics 10/2021 - 01/2020
1	Drug Therapy (Chemotherapy) 10/2021
1	Immunotherapy 01/2020
1	Intravenous Administration 05/2015